Navigation Links
Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
Date:9/4/2013

CARLSBAD, Calif., Sept. 4, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2013 at 2:05 p.m. ET in New York, NY.

(Logo:  http://photos.prnewswire.com/prnh/20130807/LA60006LOGO)

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's website, www.isispharm.com.  A replay will be available on the Isis website within 48 hours and will be archived for a limited time.

About Isis Pharmaceuticals, Inc.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 29 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO™, in the United States for the treatment of patients with HoFH.  Genzyme is also pursuing marketing approval of KYNAMRO in other markets.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

Forward-Looking Statements
This press release includes forward-looking statements regarding Isis' business and the therapeutic potential of Isis' technologies and products in development.  Any statement describing Isis' goals, expectations, financial or other
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
2. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
3. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
4. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
5. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
6. Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
7. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
8. AcelRx Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
9. Alexza Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
10. Edison expands North American healthcare sector coverage with initiation of coverage on Alexza Pharmaceuticals
11. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Ophthalmic Compound Development Opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015 The North American dental ... is estimated to reach $90.7 million by 2019, at a ... through the TOC of North America Dental Lasers Market for ... of various tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ... this report.   Dental lasers are specifically ...
(Date:5/22/2015)... PRUSSIA, Pa. , May 22, 2015  The ... its 2015 Corporate Leadership Award as recognition for the ... the care of the bleeding disorders community.  The award was ... CSL Limited, during the NHF Annual Spring Soiree in ... "The National Hemophilia Foundation is dedicated to finding better ...
(Date:5/22/2015)... May 22, 2015 According to ... by Product (Consumables, Instruments, Services), by Test Type (Indirect, ... Flow Cytometry), by End Users - Global Forecast to ... is expected to reach $736.85 Million by 2020 from ... 10.25%. Browse 71 market data Tables ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... Fulcrum Ventures announced today that they invested $1.25 million in Path-Tec, LLC.  Founded in ... management and patient specimen tracking.  Based in Columbus, Georgia , Path-Tec positions itself as a complete outsourcing ... ... , ...
... WASHINGTON , March 22 Allan Coukell , director of the Pew Prescription Project, issued the following statement ... device companies to publicly report the gifts and payments they make to doctors.   , ... ... ...
Cached Medicine Technology:Fulcrum Ventures Leads $1.25 Million Investment in Path-Tec, LLC 2Fulcrum Ventures Leads $1.25 Million Investment in Path-Tec, LLC 3Pew Statement on the Physician Payments Sunshine Act 2
(Date:5/25/2015)... A recent report for Mass Live ... died as a direct result of an opiate overdose in ... rise in overdose deaths attributed to prescription opiate medications, and ... care about geography. This issue doesn’t care about race. This ... class.” As the state of Mass. reels from the effects ...
(Date:5/25/2015)... Join Fiona's Soccer Camp at Novato High School's Tibi ... National Player, Fiona O'Sullivan will be on site to run ... coaching style. Fiona has three camps running this summer in ... Lynwood Elmentary School (June 15-19) and Hill Recreation Center (June ... 2015 - 1:00-3:00pm. Bring a Soccer Ball, Cleats and a ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 Decora Preset ... ‘Leviton’ is now available on ‘The Hardware City.’ The product ... has to set a time and the related electronic device ... contacted a representative of the company said, “We are glad ... City.’ Now customers can buy Countdown Timer Switch in just ...
(Date:5/24/2015)... 2015 For people who are keen ... Industry, 2009-2019 Market Research Report would be an useful ... study on the present market scenario of this industry. ... growing Chinese market of this industry. The report summarizes ... of the manufacturers in this industry. The report is ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 The ... ( http://www.testosteronelawsuithub.com/ ) has scheduled its next monthly ... the multidistrict litigation. According to court documents filed ... Illinois, the Conference will be convened on June ... Replacement Therapy Product Liability Litigation - MDL No. ...
Breaking Medicine News(10 mins):Health News:Opioid Deaths Increase by 33 Percent Since 2012 in Mass. 2Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3
... NEW YORK, Jan. 18 In football, ... to snacking during football games, defending,against heartburn ... the game as well., (Listen ... http://media.medialink.com/WebNR.aspx?story=34345 ) Registered journalists can access ...
... 2 men taking the product , , FRIDAY, Jan. 18 ... a dietary supplement appears to have contributed to the ... report. , "There were things on the label that ... product that were not on the label," said study ...
... and only medication approved to reduce both A1C ... Daiichi Sankyo, Inc.,announced today that the United ... (colesevelam HCl) to improve glycemic control,(measured as hemoglobin ... in,combination with metformin, sulfonylureas, or insulin, either alone ...
... Joined by New York City Mayor,Michael Bloomberg, ... Carmona today discussed Lance,s request to the Surgeons ... cancer., "This year alone, 1.4 million Americans ... will likely lose their lives to the disease," ...
... led to aggressive disease in 2 men taking the ... mislabeled over-the-counter product described as a dietary supplement appears ... cancer in two men, researchers report. , "There were ... product, and components in the product that were not ...
... diabetes care improvement at a community-level, WASHINGTON, ... in implementing and evaluating models for improving diabetes ... on Health,(NBCH) announced the recipients of its first ... member coalitions -- intended to support the,initial stages ...
Cached Medicine News:Health News:Mislabeled Supplement Spurred Prostate Cancer: Report 2Health News:Mislabeled Supplement Spurred Prostate Cancer: Report 3Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 2Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 3Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 4Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 5Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 6Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 7Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 3Health News:Mislabled Supplement Spurred Prostate Cancer: Report 2Health News:Mislabled Supplement Spurred Prostate Cancer: Report 3Health News:National Business Coalition on Health Awards Grants to 14 Coalitions for Diabetes Quality Programs 2Health News:National Business Coalition on Health Awards Grants to 14 Coalitions for Diabetes Quality Programs 3
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
... Spaced, Expandable, Multichannel Pipettor The ... boosts productivity with an industry breakthroughequal tip ... of a slide rod. This innovation allows ... between vessels with different configurations. Adjustable ...
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... Ergonomic Design for Unparalleled Comfort ... it. Notice the balance. Notice the trigger and ... left-handed. Thats because our pipettors are ergonomically designed ... long hours of pipetting. Productivity In The ...
Medicine Products: